Envista Holdings (NVST)

$16.32

-0.25

(-1.51%)

Market is closed - opens 7 PM, 23 Jul 2024

Performance

  • $16.14
    $16.46
    $16.32
    downward going graph

    1.1%

    Downside

    Day's Volatility :1.94%

    Upside

    0.85%

    downward going graph
  • $15.70
    $36.14
    $16.32
    downward going graph

    3.8%

    Downside

    52 Weeks Volatility :56.56%

    Upside

    54.84%

    downward going graph

Returns

PeriodEnvista HoldingsSector (Health Care)Index (Russel 2000)
3 Months
-17.6%
6.0%
0.0%
6 Months
-31.22%
5.6%
0.0%
1 Year
-53.59%
8.5%
0.0%
3 Years
-60.38%
13.8%
-19.6%

Highlights

Market Capitalization
2.8B
Book Value
$24.09
Earnings Per Share (EPS)
-0.73
Wall Street Target Price
19.25
Profit Margin
-4.7%
Operating Margin TTM
8.82%
Return On Assets TTM
2.91%
Return On Equity TTM
-2.86%
Revenue TTM
2.6B
Revenue Per Share TTM
15.17
Quarterly Revenue Growth YOY
-0.6%
Gross Profit TTM
1.5B
EBITDA
437.3M
Diluted Eps TTM
-0.73
Quarterly Earnings Growth YOY
-0.45
EPS Estimate Current Year
1.19
EPS Estimate Next Year
1.36
EPS Estimate Current Quarter
0.31
EPS Estimate Next Quarter
0.35

Analyst Recommendation

Buy
    47%Buy
    42%Hold
    10%Sell
Based on 19 Wall street analysts offering stock ratings for Envista Holdings(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
10
12
Hold
8
7
5
Sell
2
2
1

Analyst Forecast

What analysts predicted

Upside of 17.95%

Current $16.32
Target $19.25

Company Financials

FY18Y/Y Change
Revenue
2.8B
↑ 1.2%
Net Income
230.7M
↓ 23.38%
Net Profit Margin
8.11%
↓ 2.6%
FY19Y/Y Change
Revenue
2.8B
↓ 3.27%
Net Income
217.6M
↓ 5.68%
Net Profit Margin
7.91%
↓ 0.2%
FY20Y/Y Change
Revenue
2.3B
↓ 17.07%
Net Income
33.3M
↓ 84.7%
Net Profit Margin
1.46%
↓ 6.45%
FY21Y/Y Change
Revenue
2.5B
↑ 9.94%
Net Income
263.5M
↑ 691.29%
Net Profit Margin
10.5%
↑ 9.04%
FY22Y/Y Change
Revenue
2.6B
↑ 2.4%
Net Income
243.1M
↓ 7.74%
Net Profit Margin
9.46%
↓ 1.04%
FY23Y/Y Change
Revenue
3.7B
↑ 43.73%
Net Income
-100.2M
↓ 141.22%
Net Profit Margin
-2.71%
↓ 12.17%
Q4 FY22Q/Q Change
Revenue
660.8M
↑ 4.71%
Net Income
73.5M
↑ 54.41%
Net Profit Margin
11.12%
↑ 3.58%
Q1 FY23Q/Q Change
Revenue
627.2M
↓ 5.08%
Net Income
43.8M
↓ 40.41%
Net Profit Margin
6.98%
↓ 4.14%
Q2 FY23Q/Q Change
Revenue
662.4M
↑ 5.61%
Net Income
51.9M
↑ 18.49%
Net Profit Margin
7.84%
↑ 0.86%
Q3 FY23Q/Q Change
Revenue
631.3M
↓ 4.7%
Net Income
21.5M
↓ 58.57%
Net Profit Margin
3.41%
↓ 4.43%
Q4 FY23Q/Q Change
Revenue
645.6M
↑ 2.27%
Net Income
-217.4M
↓ 1111.16%
Net Profit Margin
-33.67%
↓ 37.08%
Q1 FY24Q/Q Change
Revenue
623.6M
↓ 3.41%
Net Income
23.6M
↓ 110.86%
Net Profit Margin
3.78%
↑ 37.45%
FY18Y/Y Change
Total Assets
5.8B
↓ 2.52%
Total Liabilities
1.0B
↑ 1.7%
FY19Y/Y Change
Total Assets
6.2B
↑ 5.42%
Total Liabilities
2.6B
↑ 157.63%
FY20Y/Y Change
Total Assets
6.9B
↑ 11.65%
Total Liabilities
3.2B
↑ 20.63%
FY21Y/Y Change
Total Assets
6.6B
↓ 4.39%
Total Liabilities
2.5B
↓ 20.25%
FY22Y/Y Change
Total Assets
6.6B
↑ 0.19%
Total Liabilities
2.4B
↓ 5.41%
FY23Y/Y Change
Total Assets
6.6B
↑ 0.27%
Total Liabilities
2.4B
↑ 2.15%
Q4 FY22Q/Q Change
Total Assets
6.6B
↑ 2.73%
Total Liabilities
2.4B
↓ 3.01%
Q1 FY23Q/Q Change
Total Assets
6.6B
↓ 0.18%
Total Liabilities
2.3B
↓ 3.53%
Q2 FY23Q/Q Change
Total Assets
6.6B
↑ 0.49%
Total Liabilities
2.3B
↑ 0.01%
Q3 FY23Q/Q Change
Total Assets
6.7B
↑ 1.16%
Total Liabilities
2.4B
↑ 4.11%
Q4 FY23Q/Q Change
Total Assets
6.6B
↓ 1.18%
Total Liabilities
2.4B
↑ 1.7%
Q1 FY24Q/Q Change
Total Assets
6.6B
↓ 0.74%
Total Liabilities
2.4B
↓ 0.63%
FY18Y/Y Change
Operating Cash Flow
400.1M
↑ 11.42%
Investing Cash Flow
-75.5M
↑ 37.52%
Financing Cash Flow
-324.6M
↑ 6.71%
FY19Y/Y Change
Operating Cash Flow
397.5M
↓ 0.65%
Investing Cash Flow
-78.4M
↑ 3.84%
Financing Cash Flow
-107.7M
↓ 66.82%
FY20Y/Y Change
Operating Cash Flow
283.9M
↓ 28.58%
Investing Cash Flow
-69.1M
↓ 11.86%
Financing Cash Flow
492.5M
↓ 557.29%
FY21Y/Y Change
Operating Cash Flow
391.4M
↑ 37.87%
Investing Cash Flow
232.9M
↓ 437.05%
Financing Cash Flow
-465.6M
↓ 194.54%
FY22Y/Y Change
Operating Cash Flow
182.7M
↓ 53.32%
Investing Cash Flow
-657.3M
↓ 382.22%
Financing Cash Flow
12.5M
↓ 102.68%
Q4 FY22Q/Q Change
Operating Cash Flow
110.3M
↑ 136.19%
Investing Cash Flow
-1.1M
↓ 98.42%
Financing Cash Flow
-68.3M
↓ 192.67%
Q1 FY23Q/Q Change
Operating Cash Flow
3.1M
↓ 97.19%
Investing Cash Flow
-22.0M
↑ 1900.0%
Financing Cash Flow
-1.5M
↓ 97.8%
Q2 FY23Q/Q Change
Operating Cash Flow
75.1M
↑ 2322.58%
Investing Cash Flow
-2.8M
↓ 87.27%
Financing Cash Flow
2.6M
↓ 273.33%
Q3 FY23Q/Q Change
Operating Cash Flow
95.5M
↑ 27.16%
Investing Cash Flow
-25.0M
↑ 792.86%
Financing Cash Flow
114.5M
↑ 4303.85%

Technicals Summary

Sell

Neutral

Buy

Envista Holdings is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Envista Holdings
Envista Holdings
-2.13%
-31.22%
-53.59%
-60.38%
-40.72%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
6.05%
21.07%
40.63%
40.16%
154.91%
Resmed Inc.
Resmed Inc.
11.5%
14.89%
-6.88%
-21.13%
64.31%
Becton, Dickinson And Company
Becton, Dickinson And Company
-2.19%
-2.18%
-17.58%
-7.46%
-8.62%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-3.95%
-8.41%
-15.46%
-14.99%
158.45%
Alcon Ag
Alcon Ag
0.1%
13.85%
7.74%
27.84%
50.52%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Envista Holdings
Envista Holdings
22.44
NA
NA
1.19
-0.03
0.03
NA
24.09
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
71.38
71.38
7.13
6.29
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
31.37
31.37
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
49.52
49.52
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
41.68
41.68
6.72
7.76
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
42.7
42.7
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Envista Holdings
Envista Holdings
Buy
$2.8B
-40.72%
22.44
-4.7%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$147.6B
154.91%
71.38
27.16%
Resmed Inc.
Resmed Inc.
Buy
$30.0B
64.31%
31.37
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.0B
-8.62%
49.52
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.2B
158.45%
41.68
19.42%
Alcon Ag
Alcon Ag
Buy
$44.5B
50.52%
42.7
10.96%

Insights on Envista Holdings

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 645.6M → 623.6M (in $), with an average decrease of 3.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -217.4M → 23.6M (in $), with an average increase of 1021.2% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 35.2% return, outperforming this stock by 88.3%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 40.2% return, outperforming this stock by 100.6%

Institutional Holdings

  • BlackRock Inc

    12.05%
  • Vanguard Group Inc

    9.97%
  • Morgan Stanley - Brokerage Accounts

    9.84%
  • Harris Associates L.P.

    5.68%
  • Ariel Investments, LLC

    5.17%
  • Dimensional Fund Advisors, Inc.

    3.92%

Company Information

we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho

Organization
Envista Holdings
Employees
12800
CEO
Mr. Amir Aghdaei
Industry
Health Technology

FAQs